Clinical Trial Update: Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains [Phase 1, Phase 2]

View source ↗

Summary

A University of Cincinnati-led clinical trial is evaluating modulation of spinal interoceptive pathways as a treatment strategy for major depressive disorder, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of Cincinnati | Conditions: Depression - Major Depressive Disorder | Phase 1, Phase 2 | Status: RECRUITING